Faculty of Dentistry Suez Canal University
Ismailia, Egypt
NCT Number: NCT07374536
Clinical and Radiographic Evaluation of Local Application of Melatonin on Postoperative Outcomes after Surgical Removal of Impacted Mandibular Third Molar: A Randomized Controlled Study
This study is active but is not currently recruiting participants.
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Ismailia, Egypt
of all impacted teeth. The frequency of impaction of the mandibular third molar ranges from 33% to 58.7%. A tooth is considered to be impacted when its eruption time has passed or when the eruption interferes with the normal functional occlusion with other teeth or the overlying bone or soft tissues in the oral cavity.
The surgical removal of an impacted third molar is an everyday procedure in oral surgery clinics. However, it is known to disturb the quality of life of the patient by restricting the ability to chew food, open the mouth, and speak. Furthermore, there is a danger of periodontal damage on the distal root of the adjacent molar which could affect healing, 43% of the patients had a periodontal pocket depth of 7 mm or more at the distal root of the mandibular second molar 2 years post extraction of an impacted mandibular third molar.
The healing of periodontal defects related to the distal root of the adjacent molar may be compromised by intra-bony defects and bone loss after the removal of the impacted tooth. Alternative strategies, such as different flap designs, soft-tissue suturing, socket preservation, and tissue regeneration techniques with autologous bone, allografts, xenografts, or alloplastic grafts, have been proposed to prevent periodontal defects and physiological bone resorption after the surgical extraction of the mandibular third molar.
Melatonin is a growth hormone secreted mainly by the pineal gland and other structures, such as the retina, skin, gastrointestinal tract, lymphocytes, and bone marrow.It has antioxidant and anti inflammatory properties. It inhibits the production of reactive oxidants by reducing the expression of cyclooxygenase-2 and prostaglandin. In addition, it attracts polymorphonuclear cells to the site of injury.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
1)Both genders are included. 2)Adult patients (18-40) years 3)Healthy American Society of Anesthesiologists ASA I Patients. 4)Patients with class I or II impacted lower third molars with position A or B.
-
Exclusion criteria
the extraction socket will be left empty followed by suture of the socket after extraction
3 mg of melatonin into 2 ml of 2% hydroxyethyl cellulose gel will be packed into the socket after extraction
Time frame: 1 and 4 months postoperatively
Assess relative bone density at the center of the extracted socket using digital periapical radiograph in the center of the socket.
Time frame: 1, 3 and 7 days Postoperatively
Post-operative pain levels by VAS (Visual Analog Scale) Minimum Score: 0 (no pain) Maximum Score: 10 (severe pain that completely prevent daily activities)
Time frame: 1, 3 and 7 days Postoperatively
Measure Edema scale using flexible ruler (It depends on the patient's own facial measurements and returning to normal measurements).
Time frame: 1, 3 and 7 days Postoperatively
Measure Maximal Mouth opening (MMO) using digital caliper.
Time frame: 1, 3 and 7 days Postoperatively
Measure the incidence of post-operative complications (e.g., dry socket, infection) in both groups.
Suez Canal University
Other
Clinical and Radiographic Evaluation of Local Application of Melatonin on Postoperative Outcomes After Surgical Removal of Impacted Mandibular Third Molar: A Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07652216
Autogenous Dentin Graft, Bone Cysts
Krakow, Malopolska, Poland
View Trial DetailsNCT06513260
Dental Anxiety, Impact Molar
Kütahya, Turkey (Türkiye)
View Trial Details